Bal Pharma has informed that it enclosed copies of the newspaper advertisements of abridged standalone and consolidated financial results of the Company for the quarter and nine months ended 31.12.2023, announced by the Company on 12.02.2024 and published in Financial Express (English) and Sanjayvani (Kannada) on 13.02.2024.
The above information is a part of company’s filings submitted to BSE.